These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28736077)

  • 1. Replication of the Zika virus in different iPSC-derived neuronal cells and implications to assess efficacy of antivirals.
    Lanko K; Eggermont K; Patel A; Kaptein S; Delang L; Verfaillie CM; Neyts J
    Antiviral Res; 2017 Sep; 145():82-86. PubMed ID: 28736077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals.
    Tricot T; Helsen N; Kaptein SJF; Neyts J; Verfaillie CM
    PLoS One; 2018; 13(12):e0209097. PubMed ID: 30566505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
    Kim JA; Seong RK; Kumar M; Shin OS
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
    Adcock RS; Chu YK; Golden JE; Chung DH
    Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.
    Zmurko J; Marques RE; Schols D; Verbeken E; Kaptein SJ; Neyts J
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004695. PubMed ID: 27163257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
    Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
    Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
    Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks Zika virus replication.
    de Carvalho OV; Félix DM; de Mendonça LR; de Araújo CMCS; de Oliveira Franca RF; Cordeiro MT; Silva Júnior A; Pena LJ
    Int J Antimicrob Agents; 2017 Dec; 50(6):718-725. PubMed ID: 28803932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.
    Cai L; Sun Y; Song Y; Xu L; Bei Z; Zhang D; Dou Y; Wang H
    Arch Virol; 2017 Sep; 162(9):2847-2853. PubMed ID: 28597088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
    Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
    Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
    Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
    Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phloretin inhibits Zika virus infection by interfering with cellular glucose utilisation.
    Lin SC; Chen MC; Liu S; Callahan VM; Bracci NR; Lehman CW; Dahal B; de la Fuente CL; Lin CC; Wang TT; Kehn-Hall K
    Int J Antimicrob Agents; 2019 Jul; 54(1):80-84. PubMed ID: 30930299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of African and Asian Lineage-Derived Zika Virus Strains Reveals Differences in Activation of and Sensitivity to Antiviral Innate Immunity.
    Esser-Nobis K; Aarreberg LD; Roby JA; Fairgrieve MR; Green R; Gale M
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles.
    Albulescu IC; Kovacikova K; Tas A; Snijder EJ; van Hemert MJ
    Antiviral Res; 2017 Jul; 143():230-236. PubMed ID: 28461070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.
    Tong X; Smith J; Bukreyeva N; Koma T; Manning JT; Kalkeri R; Kwong AD; Paessler S
    Antiviral Res; 2018 Jan; 149():34-40. PubMed ID: 29126899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Oxysterol 7-Ketocholesterol Reduces Zika Virus Titers in Vero Cells and Human Neurons.
    Willard KA; Elling CL; Stice SL; Brindley MA
    Viruses; 2018 Dec; 11(1):. PubMed ID: 30598036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Viral Polymerase Inhibitor Reduces Zika Virus Replication in the Reproductive Organs of Male Mice.
    Jacobs S; Delang L; Verbeken E; Neyts J; Kaptein SJF
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31032814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs.
    Bassi MR; Sempere RN; Meyn P; Polacek C; Arias A
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine and Sulfadoxine Derivatives Inhibit ZIKV Replication in Cervical Cells.
    de Souza AAA; Torres LR; Capobianco LRPL; de Paula VS; Cascabulho CM; Salomão K; Bonecini-Almeida MDG; Ferreira MLG; Boechat N; Pinheiro LCDS; de Souza EM
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33383619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
    Pires de Mello CP; Tao X; Kim TH; Vicchiarelli M; Bulitta JB; Kaushik A; Brown AN
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.